Loading JNJ charts…
May we use analytics cookies to see how vpside is used, including anonymous session recordings? Accepting also loads the price chart, which sets its own cookies. Essential cookies are always on. Privacy
Loading JNJ comparable companies…
| JNJJohnson & Johnson(opens in a new tab) | $669.08B | $99.33B | +7.8% | 67.6% | 29.6% | 6.74× | 41.5× |
|---|---|---|---|---|---|---|---|
| PFEPfizer Inc.(opens in a new tab) | $173.82B | $63.70B | −0.2% | 73.2% | — | 2.73× | 40.1× |
| MRKMerck & Co., Inc.(opens in a new tab) | $369.36B | $66.57B | +4.6% | 73.0% | — | 5.55× | 118.7× |
| ABBVAbbVie Inc.(opens in a new tab) | $522.12B | $64.39B | +10.4% | 71.5% | 26.2% | 8.11× | 83.3× |
| ABTAbbott Laboratories(opens in a new tab) | $185.17B | $46.59B | +8.1% | 56.6% | 15.8% | 3.97× | 34.3× |
| Medianpeers, excl. JNJ | $277.27B | $64.04B | +6.4% | 72.2% | 21.0% | 4.76× | 61.7× |